|BTGGF -- USA Stock|| |
USD 7.46 0.01 0.13%
We currently do not have informatin regarding Andy Burrows. This executive tanure with BTG plc is not currenlty determined.
VP Since 2017
44 20 7575 0000 http://www.btgplc.com
The company has return on total asset (ROA)
of 5.49 %
which means that it generated profit of $5.49 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 1.34 %
meaning that it generated $1.34 on every $100 dollars invested by stockholders.
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom. BTG plc operates under Biotechnology classification in USA and traded on OTC Market. It employs 1631 people.BTG plc (BTGGF) is traded on OTC Market in USA. It is located in 5 Fleet Place and employs 1,631 people.
BTG plc Leadership Team
|Melanie Lee, Independent Non-Executive Director|
|Graham Hetherington, Non-Executive Director|
|Richard Wohanka, Independent Non-Executive Director|
|Giles Kerr, Senior Independent Non-Executive Director|
|Garry Watts, Non-Executive Chairman of the Board|
|Gregory Barrett, Non-Executive Director|
|Anne Thorburn, Non-Executive Director|
|Rolf Soderstrom, CFO, Executive Director|
|Duncan Kennedy, CFO|
|Andy Burrows, VP of Corporate and Investor Relations|
|Ian Much, Independent Non-Executive Director|
|Dame Makin, CEO, Executive Director|
|WJames OShea, Independent Non-Executive Director|
|Paul Mussenden, General Counsel and Company Secretary|
|Susan Foden, Non-Executive Director|
Stock Performance Indicators
Macroaxis portfolio users are unresponsive in their opinion about investing in BTG plc. What is your opinion about investing in BTG plc? Are you bullish or bearish?
and pair trading evaluation for BTG plc and Alamos Gold
. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return